Article
VEXAS syndrome: A review of cutaneous findings and treatments in an emerging autoinflammatory disease.
Experimental dermatology - 1 Mar 2024
Saad Anis J, Patil Mihir K, Cruz Nicolas, Lam Chloe S, O'Brien Connor, Nambudiri Vinod E
Abstract excerpt
VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory and somatic mutation) syndrome is a novel autoinflammatory, late-onset, disorder first identified in 2020. It is caused by mutations in the UBA1 gene. The most prominent clinical features reported by VEXAS patients are cutaneous and haematological, having characteristic skin features reported as the initial presenting findings of the disease. VEXAS is a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
